期刊文献+

Decursin Mediated Protection on Cisplatin-induced Nephrotoxicity in SD Rats and BDF1 Mice

Decursin Mediated Protection on Cisplatin-induced Nephrotoxicity in SD Rats and BDF1 Mice
下载PDF
导出
摘要 Tisplatin is one of the valuable icancer agents against several types of neoplasm. However, nephrotoxicity is the major adverse effect representing in cisplatin therapy. In this study, the animal tests detecting protective effects of a natural compound, Decursin, on cisplatin-induced nephrotoxicity were examined by using in vivo model. Pretreatment Decursin 10, 20 and 40 mg · kg^-1 at 48, 24 and 6 h, and administration of a single dose of Cisplatin 5.2 mg · kg^-1. Nephrotoxicity was evaluated by serum BUN and creatinine examination. There was significant difference in body weights, serum BUN and creatinine levels of the normal group. Based on the new understanding of the protective mechanisms of cisplatin-induced nephrotocivity, new strategies can be developed to prevent renal injury or to enhance recovery after cisplatin treatment. Tisplatin is one of the valuable icancer agents against several types of neoplasm. However, nephrotoxicity is the major adverse effect representing in cisplatin therapy. In this study, the animal tests detecting protective effects of a natural compound, Decursin, on cisplatin-induced nephrotoxicity were examined by using in vivo model. Pretreatment Decursin 10, 20 and 40 mg · kg^-1 at 48, 24 and 6 h, and administration of a single dose of Cisplatin 5.2 mg · kg^-1. Nephrotoxicity was evaluated by serum BUN and creatinine examination. There was significant difference in body weights, serum BUN and creatinine levels of the normal group. Based on the new understanding of the protective mechanisms of cisplatin-induced nephrotocivity, new strategies can be developed to prevent renal injury or to enhance recovery after cisplatin treatment.
出处 《Journal of Northeast Agricultural University(English Edition)》 CAS 2012年第1期50-56,共7页 东北农业大学学报(英文版)
关键词 CISPLATIN DECURSIN NEPHROTOXICITY rat MICE cisplatin, Decursin, nephrotoxicity, rat, mice
  • 相关文献

参考文献17

  • 1Andrews P A, Murphy M P, Howell S B. 1986. Differential sensitiza- tion of human ovarian carcinoma an mouse L1210 cells to cisplatin and melphalan by glutathione depletion. Mol Pharmacol, 30: 643-650.
  • 2Atessahin A, Ceribasi A O, Yuce A, et al. 2006. Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats. Basic & Clineal Pharmacology & Toxicology, 1 O0: 121 - 126.
  • 3Blachley J D, Hill J t3. 1981. Renal and electrolyte disturbances associated with cisplatin. Ann Inter Med, 95: 628-632.
  • 4Daugaard G, Abidgaard U, Holstein-Rathlou N H, et al. 1986. Acute effect o cisplatin on renal hemodynamics and tubular funcition in dogkidney. Renal Physiol, 9:308-316.
  • 5Daugaard G, Avildgaard U, Holstein-Rathlou N H, et al. 1988. Renal tubular function in patients treated with high-dose cisplatin. Clin Pharmacol Ther, 44: 164-172.
  • 6Deconti R C, Toftness B R, Lange R C, et al. 1973. Clinical and pharmacological studies with cis-diamminedichloroplatinum(2). CancerRes, 33: 1310-1315.
  • 7Dobyan D C, Levi J, Jacobs C, et al. 1980. Mechanism of cis-platinum nephrotoexicity. Morphologic observations. J Pharmacol Exp Ther, 32: 551-556.
  • 8Hamilton T C, Winker M A, Louie K G, et al. 1985. Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistan and sensitive human ovarian carcinoma cell lines by buthionine sufoximine mediated glutathione depleton. Biochem Pharmacol, 34: 2583-2586.
  • 9Jiang M, Wei Q, Pabla N, et al. 2007. Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity. Biochem Pharmacol, 73:1499-1510.
  • 10Kim J H, Jeong J H, Jeon S T, et al. 2006. Decursin inhibits induction of inflammatory mediators by blocking nuclear factor-kB activation in macrophages. Mol Pharmacol, 69: 1783-1790.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部